Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy
Yalong Dang,1–3,# Xinfeng Sun,2,# Yongsheng Xu,3,# Yalin Mu,2 Manli Zhao,2 Jing Zhao,2 Yu Zhu,1 Chun Zhang31Department of Ophthalmology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 2Department of Ophthalmology, Yellow River Hospital, Henan University of Sc...
Saved in:
Main Authors: | Dang Y (Author), Sun X (Author), Xu Y (Author), Mu Y (Author), Zhao M (Author), Zhao J (Author), Zhu Y (Author), Zhang C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients
by: Dang Y, et al.
Published: (2013) -
Central Serous Chorioretinopathy Classification
by: Manuel Vilela, et al.
Published: (2020) -
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization
by: E Seul Kim, et al.
Published: (2021) -
Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
by: Pierluigi Iacono, et al.
Published: (2020) -
Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
by: Yu Wakatsuki, et al.
Published: (2021)